Analysis of participant-reported adverse events following the first dose of inactivated SARS-Cov-2 vaccine (TURKOVAC™) through telephone survey in Türkiye

Ateş Karaa Pediatric Infectious Disease Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, TurkeyCorrespondence[email protected]

https://orcid.org/0000-0002-1654-3232 View further author information

Aslihan Coskunb Health Institutes of Türkiye, Turkish Vaccine Institute, Ankara, TurkeyView further author information

Fehminaz Temelc Field Epidemiology Unit, General Directorate of Public Health, Department of Communicable Diseases and Early Warning, Ministry of Health, Ankara, TurkeyView further author information

Pervin Özelcib Health Institutes of Türkiye, Turkish Vaccine Institute, Ankara, TurkeyView further author information

Selmur Topalc Field Epidemiology Unit, General Directorate of Public Health, Department of Communicable Diseases and Early Warning, Ministry of Health, Ankara, TurkeyView further author information

Ihsan Ateşd Ankara City Hospital, Internal Medicine Clinic, Ankara, Turkey

https://orcid.org/0000-0003-2858-6229 View further author information

Analysis of participant-reported adverse events following the first dose of inactivated SARS-Cov-2 vaccine (TURKOVAC™) through telephone survey in Türkiye

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Analysis of participant-reported adverse events following the first dose of inactivated SARS-Cov-2 vaccine (TURKOVAC™) through telephone survey in Türkiye

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date